1279031-70-7
1279031-70-7
Chemical Structure
Rosuvastatin-d3 sodium
- CAS No.: 1279031-70-7
- Formula:C22H24D3FN3NaO6S
- Molecular Weight:506.54
IUPAC Name: sodium (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-(methyl-d3)methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate
InChIKey: RGEBGDYYHAFODH-SYRJKFITSA-M
SMILES: O=C([O-])C[C@H](O)C[C@H](O)/C=C/C1=C(C(C)C)N=C(N(C([2H])([2H])[2H])S(=O)(C)=O)N=C1C2=CC=C(F)C=C2.[Na+]
Biological Activity: Rosuvastatin-d3 (sodium) is deuterium labeled Rosuvastatin.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rosuvastatin-d3 sodium | 99.10% | Rosuvastatin-d3 (sodium) is deuterium labeled Rosuvastatin. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rosuvastatin Sodium (Standard) | ≥98% | Rosuvastatin (Sodium) (Standard) is the analytical standard of Rosuvastatin (Sodium). This product is intended for research and analytical applications. Rosuvastatin Sodium is a competitive HMG-CoA reductase (HMGCR) inhibitor, with an IC50 of 11 nM. Rosuvastatin Sodium potently blocks hERG current with an IC50 of 195 nM. Rosuvastatin Sodium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Sodium effectively lowers low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rosuvastatin-d6 sodium | 99.9% | Rosuvastatin-d6 sodium is deuterium labeled Rosuvastatin sodium (HY-17504B). Rosuvastatin Sodium is a competitive HMG-CoA reductase (HMGCR) inhibitor, with an IC50 of 11 nM. Rosuvastatin Sodium potently blocks hERG current with an IC50 of 195 nM. Rosuvastatin Sodium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Sodium effectively lowers low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rosuvastatin-13C,d3 sodium | 98.31% | Rosuvastatin-13C,d3 sodium is 13C and deuterated labeled Rosuvastatin sodium (HY-17504B). Rosuvastatin Sodium is a competitive HMG-CoA reductase (HMGCR) inhibitor, with an IC50 of 11 nM. Rosuvastatin Sodium potently blocks hERG current with an IC50 of 195 nM. Rosuvastatin Sodium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Sodium effectively lowers low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rosuvastatin Sodium | 99.91% | Rosuvastatin Sodium is a competitive HMG-CoA reductase (HMGCR) inhibitor, with an IC50 of 11 nM. Rosuvastatin Sodium potently blocks hERG current with an IC50 of 195 nM. Rosuvastatin Sodium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Sodium effectively lowers low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
